GlassScriptPhysician profile
Clarence James Red, III
NPI 1740409663
$2,805.57
in general payments reported to CMS, 2019-2025
9 companies · $46.19 in 2025
The $46.19 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $57.36 · 2021: $677 · 2022: $1,058 · 2023: $699 · 2024: $159 · 2025: $46.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674 · Education: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.67 |
| Education | $230.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3m Company | $1,929.48 | 2019-2023 | Clarity Aligners, Apc Flash-Free Victory Series Low Profile |
| Ormco Corporation | $237.32 | 2022-2023 | Spark |
| Nobel Biocare USA | $219.17 | 2023 | Nobelactive |
| Lightforce Orthodontics, INC. | $158.57 | 2023 | |
| USA Angelalign Technology Corp | $149.75 | 2023-2024 | |
| Solventum Corporation | $61.46 | 2024-2025 | Clarity Aligners, Clarity Advanced |
| Envista Holdings Corporation | $18.94 | 2025 | Bluegloo |
| Dentsply Sirona INC | $16.64 | 2021 | |
| Philips North America LLC | $14.24 | 2024 | (E55) Oral Health Care Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clarence Red listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.